HDB launches EC site in Yishun, extends tender period to 6 months due to Covid-19

Published Thu, Apr 30, 2020 · 03:52 AM

[SINGAPORE] The Housing Board (HDB) on Thursday launched the sale of an executive condominium (EC) site at Yishun Avenue 9, and extended the public tender period to six months due to the coronavirus outbreak.

The longer period will provide developers with additional time to make their assessment in view of the current Covid-19 situation, HDB said in media release. The tender duration for GLS residential sites typically ranges from six to eight weeks.

The tender for the 99-year leasehold land parcel will close at noon on Oct 29.

The site spans 21,514 square metres and can potentially yield about 600 residential units. It is located within 500 metres to Junction 9, a relatively new neighbourhood mall.

It is the first of three confirmed list residential sites to be launched for sale under the government land sales (GLS) programme for the first half of 2020.

The other two sites consist of a parcel at Tanah Merah Kechil Link, next to Tanah Merah MRT station, which can yield 310 housing units and a mixed residential and commercial plot at Jalan Anak Bukit which can accommodate 865 units. The Jalan Anak Bukit site will have a bus interchange with an underground connection to nearby Beauty World MRT station on the Downtown Line.

A NEWSLETTER FOR YOU
Tuesday, 12 pm
Property Insights

Get an exclusive analysis of real estate and property news in Singapore and beyond.

The government kept steady the amount of private residential housing from GLS programme for the first half of this year, in view of the supply overhang and as developers' bids for land moderated after property cooling measures.

THE STRAITS TIMES

KEYWORDS IN THIS ARTICLE

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to  t.me/BizTimes

Property

SUPPORT SOUTH-EAST ASIA'S LEADING FINANCIAL DAILY

Get the latest coverage and full access to all BT premium content.

SUBSCRIBE NOW

Browse corporate subscription here